The developer of Russia’s Sputnik V coronavirus vaccine said Friday it had signed a partnership with an India-based drugmaker for the production of 200 million doses of the two-dose jab.
The Russian Direct Investment Fund (RDIF), which backed the development of Sputnik V, said in a statement it had partnered with Stelis Biopharma “to produce and supply a minimum of 200 million doses of the Russian Sputnik V vaccine.”
Stelis Biopharma is expected to be able to start supplying the vaccine from the second half of the year.
RDIF, added that Stelis -- the biopharma unit of global pharmaceutical company Strides -- will work with the Russian wealth fund to provide supplies “beyond the initial agreement.”
RDIF head Kirill Dmitriev said that the “significant vaccine volumes” produced with Stelis “will help widen access to the vaccine on a global scale.”
RDIF said on Friday that 52 countries have approved the use of Russia’s Sputnik V, named after the Soviet-era satellite.
Moscow registered the jab in August before large-scale clinical trials, but leading medical journal The Lancet has since said it is safe and over 90 percent effective.
Some Western countries have been wary of Sputnik over concerns the Kremlin would use it as a soft power tool to advance its interests.
Sputnik V COVID-19 vaccine developers reach production deals in key EU states
Venezuela’s Maduro receives first dose of Sputnik V COVID-19 vaccine
Sputnik V vaccine performs well against COVID-19 mutations: Scientists
Philippines approves use of Russia’s Sputnik V vaccine as COVID-19 cases spikeThe Philippines has approved Russia’s Sputnik V COVID-19 vaccine for emergency use, the country’s Food and Drug Administration (FDA) said on Friday, ... Coronavirus
Cyprus will buy Russia’s Sputnik COVID-19 vaccine if approved by EU regulatorCyprus will acquire Russia’s Sputnik V COVID-19 vaccine if it is approved by the European Medicines Agency (EMA), a senior official said on Tuesday, ... Coronavirus
Sputnik V COVID-19 vaccine developers reach production deals in key EU statesThe developers of the Sputnik V coronavirus vaccine said Monday they had reached production agreements in key European countries as the EU’s medical ... Coronavirus
Russia’s Sputnik V could be made in Europe for first time after Italy deal signedRussia’s Sputnik V vaccine against COVID-19 could be produced in Europe for the first time after a commercial deal to produce it in Italy was signed ... Coronavirus
Venezuela’s Maduro receives first dose of Sputnik V COVID-19 vaccineVenezuelan President Nicolas Maduro and first lady Cilia Flores have received their first dose of Russia’s Sputnik V coronavirus vaccine, Venezuelan ... Coronavirus
Egypt’s drug authority approves Russia’s Sputnik V COVID-19 vaccineEgypt has approved Russia’s Sputnik V vaccine against COVID-19, becoming the 34th country outside of Russia and third in North Africa to do so, the ... Coronavirus
Sputnik V vaccine performs well against COVID-19 mutations: ScientistsA Russian trial testing the effectiveness of revaccination with the Sputnik V shot to protect against new mutations of the coronavirus is producing ... Coronavirus